0.8-100ng/ML CK-MB Test Kit Immunofluorescence Chromatography Recovered

0.8-100ng/ML CK-MB Test Kit Immunofluorescence Chromatography Recovered

CK-MB Overview

Creatine kinase isoenzyme (CK-MB) is an enzyme system widely existing in striated muscle. When myocardial injury, such as skeletal muscle, will release creatine kinase isoenzyme in the blood, which will rise after 4-6 hours, peak for 24 hours and recover for 48-72 hours.

CK-MB performance index

CK-MB Clinical significance

• Early diagnosis and risk stratification of AMI
• Mi without ST segment elevation is the most valuable marker

CK-MB Clinical value

The isoenzyme of creatine kinase is very important in clinical diagnosis. When muscle atrophy, myocardial infarction and other diseases occur, the value of creatine kinase in human serum will rise sharply. In the diagnosis of myocardial infarction, the determination of creatine kinase activity is more reliable than ECG. Creatine kinase in myocardial infarction increased within 6 hours, peaked within 24 hours and returned to normal within 3-4 days. CK MB, the isoenzyme of creatine kinase, has the highest specificity in diagnosis. Because of its important physiological function and clinical application value, creative kinase has attracted more attention and in-depth research.

CK-MB Normal value

1. Electrophoresis: CK-MB < 0.05 (CK-MB < 5%), CK-MM > 0.94 - 0.96 (CK-MM > 94% - 96%), no CK-BB or trace (no CK-BB or trace)
2. Enzyme rate method (37 ℃) CK-MB: 0 ~ 18u / L, CK-MM: 0 ~ 18u / L, CK-BB: 0U / L.

Application Department

Cardiology, emergency, examination room, pediatrics, hematology, oncology, Nephrology, surgery, etc.

CK-MB Clinical comparison

MYO Clinical Comparison

Company profile

Zhongxiu Science And Technology Co.,Ltd., is a high-tech enterprise engaged in the research and development, production and operation of in vitro diagnostic products. The in vitro diagnostic products developed by the company cover POCT series, microbial series, biochemical series and immune series reagents and supporting instruments.
The company has always adhered to the core concept of "fast and accurate, living up to life", committed to providing society with excellent products and services, and contributing to the cause of human health.

Zhongxiu Science And Technology Co.,Ltd., founded in 2016, is located in Dingluan Industrial Zone, Changyuan City, Henan Province. The company covers an area of about 100 acres and the initial investment is about 200 million yuan. The company has a scientific and complete management system, a purification workshop of national standards, and a fully functional inspection center. On this basis, the company will continue to invest in research and development, accumulate technical strength, update manufacturing equipment, improve production technology, improve inspection technology, improve product quality, and provide customers with safe and effective in vitro diagnostic products.

Zhongxiu Science And Technology Co., Ltd. is a high-tech enterprise engaged in the research and development, production and operation of in vitro diagnostic products. The in vitro diagnostic products developed by the company cover POCT series, immune series, microbial series and other reagents and supporting instruments.

The company has always adhered to the core concept of “fast and accurate, living up to life”, committed to providing society with excellent products and services, and contributing to the cause of human health.